Hubbard, OH – According to filings with the U.S. Securities and Exchange Commission, Nanologix is raising $3,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Bret Barnhizer played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Nanologix

NanoLogix, Inc. is a biotechnology company specializing in rapid diagnostics of viable microorganisms and viruses. We supply petri plates in various agars featuring a unique vacuum FlatPack flushed in argon gas. This provides an exceptionally long shelf-life. In addition to medical, national defense, and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing. Patents granted or licensed to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity.

To learn more about Nanologix, visit http://nanologix.com/

Contact:
Bret Barnhizer, President and Chief Executive Officer
330-534-0800
https://www.linkedin.com/in/bret-barnhizer-3137a113/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved